Nerve health during bladder cancer treatment
Part of Brain & nervous system clinical trials.
This study looks at nerve problems (peripheral neuropathy) in people with muscle-invasive bladder cancer who receive a combination of two drugs, enfortumab vedotin and pembrolizumab, before or after surgery. The goal is to understand how these treatments affect nerves and to help manage side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with muscle-invasive bladder cancer (cancer that has grown into the muscle layer of the bladder).
- You have not had any previous treatment for this cancer (such as chemotherapy or immunotherapy).
- You are eligible to receive the two study drugs as part of your cancer care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches for nerve problems in people getting enfortumab vedotin and pembrolizumab as their first treatment for advanced bladder cancer. It aims to understand how common these side effects are and how they affect patients.
This trial tests whether two drugs (enfortumab vedotin and pembrolizumab) work better than radiation with chemotherapy for muscle-invasive bladder cancer. The goal is to treat your cancer while keeping your bladder instead of removing it.
This study looks at different drug treatments given around the time of surgery for muscle-invasive bladder cancer. It aims to understand how well these treatments work and may help guide future care.
This study looks at a new treatment for advanced bladder cancer (urothelial carcinoma) using two drugs, enfortumab vedotin and pembrolizumab, which help the immune system fight cancer. The study also tests a supportive therapy called Neuridase to help prevent or reduce nerve damage (peripheral neuropathy) that can be a side effect of the cancer treatment.
This study looks at how enfortumab vedotin, a cancer drug, affects the nerves. It aims to understand and track neuropathy (nerve damage) in people with urothelial carcinoma, so doctors can better manage side effects.
This trial looks at how a new treatment for advanced bladder cancer, called enfortumab vedotin, might affect your nerves. It aims to understand any nerve-related side effects so doctors can better manage them.
Hear when a new Urothelial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.